Advanz Pharma Belgium
The computed 12-month bankruptcy probability of Advanz Pharma Belgium is 0.3% (very low). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 15 yrs |
| Board | 1 |
| Locations | 1 |
| Publications | 14 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 31-07-2025 | 2025-00350912 |
| 31-12-2023 | volledig | 25-07-2024 | 2024-00282901 |
| 31-12-2022 | volledig | 31-07-2023 | 2023-00313505 |
| 31-12-2021 | volledig | 15-02-2023 | 2023-00028225 |
| 31-12-2020 | volledig | 21-04-2022 | 2022-20005497 |
| 31-12-2019 | volledig | 19-03-2021 | 2021-08000066 |
| 31-12-2018 | volledig | 11-06-2019 | 2019-17700467 |
| 31-12-2017 | volledig | 07-06-2018 | 2018-16500393 |
| 31-12-2016 | volledig | 13-06-2017 | 2017-16800059 |
| 31-12-2015 | volledig | 28-06-2016 | 2016-23300156 |
-
Andreas SticklerDirectorState Gazette act 22029989 (04-03-2022)Current04-03-2022 → present
Historic, not recently confirmed (2)
-
Justin Andrew RenzGérantState Gazette act 17130583 (13-09-2017)Not recently confirmedlast confirmed in an act from 2017
-
GÜNTHER Jürgen AndreasManagerState Gazette act 12027743 (31-01-2012)Not recently confirmedlast confirmed in an act from 2012
Former directors (5)
-
Paul BURDENDirectorState Gazette act 22092578 (01-08-2022)Former- → 01-08-2022
-
Adeel AhmadDirectorState Gazette act 22029989 (04-03-2022)Former- → 04-03-2022
-
Thibaut SantiardDirectorState Gazette act 21087977 (23-07-2021)Former- → 23-07-2021
-
Jennifer ArchibaldGérantState Gazette act 17130583 (13-09-2017)Former- → 13-09-2017
-
Jürgen GüntherGérantState Gazette act 15176766 (18-12-2015)Former- → 18-12-2015
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Thomas MEURICECurrent Commissaire aux comptes |
- | 29-08-2023 → present |
Show 3 earlier auditors
| Ernst & Young Commissaire succeeded by SCRL Enst & Young in 2019 |
- | 04-07-2016 → 01-07-2019 |
| Marie Kaisin Commissaire |
- | 10-05-2022 → 29-08-2023 |
| SCRL Enst & Young Commissaire succeeded by Thomas MEURICE in 2023 |
- | 01-07-2019 → 29-08-2023 |
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 03-02-2011 |
| Status | Active |
| Postal code | 1210 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21014A0112/00K002 | Brussels | 3,162 m² | 1 · 2,256 m² | 79.3 m · 19 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 18 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
10-02-2025 Registered office moved within Bruxelles
- Avenue du Port 86C, Boîte 204, 1000 Bruxelles → Botanic Tower -6e étage, Boulevard Saint-Lazare, 4-10, 1210 Bruxelles
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Botanic Tower -6e \u00E9tage, Boulevard Saint-Lazare, 4-10, 1210 Bruxelles",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Boulevard Saint-Lazare",
"country": "BE",
"postcode": "1210",
"box_number": null,
"street_number": "4-10",
"locality_suffix": null
},
"old_address": {
"raw": "Avenue du Port 86C, Bo\u00EEte 204, 1000 Bruxelles",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Avenue du Port",
"country": "BE",
"postcode": "1000",
"box_number": "204",
"street_number": "86C",
"locality_suffix": null
},
"effective_date": "2024-12-06",
"evidence_quote": "Les administrateurs, D\u00C9CIDENT de d\u00E9placer le si\u00E8ge de la Soci\u00E9t\u00E9 de l\u0027adresse Avenue du Port 86c, bo\u00EEte 204, 1000 Bruxelles vers le Botanic Tower -6e \u00E9tage, Boulevard Saint-Lazare, 4-10, 1210 Bruxelles, \u00E0 compter du 6 d\u00E9cembre 2024.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "retroactive",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Pablo OLLOQUIEGUI",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-02-10",
"filing_date": "2025-01-09",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2025-01-09",
"unanimous": true
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Pablo OLLOQUIEGUI",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [
"Extrait des d\u00E9cisions \u00E9crites du conseil d\u0027administration d.d. 9 janvier 2025"
]
}29-08-2023 1 director appointed, 1 resigning
- Thomas MEURICE, Commissaire aux comptes
- Marie KAISIN, Commissaire aux comptes
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire aux comptes",
"person": {
"rrn": null,
"name": "Thomas MEURICE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaire aux comptes",
"person": {
"rrn": null,
"name": "Marie KAISIN",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM"
}
}01-08-2022 Paul BURDEN resigns as director
- Paul BURDEN, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Paul BURDEN",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM"
}
}10-05-2022 Marie Kaisin appointed as commissaire
- Marie Kaisin, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Marie Kaisin",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM"
}
}28-04-2022 Registered office moved from Wavre to Bruxelles
- Avenue Pasteur 6 bte H, 1300 Wavre, Belgique → Avenue du Port 86C boîte 204, 1000 Bruxelles, Belgique
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Avenue du Port 86C bo\u00EEte 204, 1000 Bruxelles, Belgique",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Avenue du Port",
"country": "BE",
"postcode": "1000",
"box_number": "204",
"street_number": "86C",
"locality_suffix": null
},
"old_address": {
"raw": "Avenue Pasteur 6 bte H, 1300 Wavre, Belgique",
"city": "Wavre",
"region": "waals_gewest",
"street": "Avenue Pasteur",
"country": "BE",
"postcode": "1300",
"box_number": "H",
"street_number": "6",
"locality_suffix": null
},
"effective_date": "2022-04-01",
"evidence_quote": "DECIDENT de transf\u00E9rer l\u0027adresse du si\u00E8ge de la Soci\u00E9t\u00E9 de Avenue Pasteur 6 bte H, 1300 Wavre, Belgique \u00E0 l\u0027Avenue du Port 86C bo\u00EEte 204, 1000 Bruxelles, Belgique, \u00E0 partir du 1er avril 2022.",
"region_changed": true,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "retroactive",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "notary\u0027s full name not specified",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-04-11",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2022-04-11",
"unanimous": true
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0833.413.211",
"org_name": "Ad-Ministerie BV",
"person_name": null,
"org_rep_person_name": "Adriaan dE LEEUW",
"person_role_at_subject": null
},
"co_filed_documents": [
"Extrait du proces-verbal de la reunion des administrateurs du 11 avril 2022"
]
}04-03-2022 1 director appointed, 1 resigning
- Andreas Stickler, Bestuurder
- Adeel Ahmad, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Adeel Ahmad",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Andreas Stickler",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM"
}
}23-07-2021 Thibaut Santiard resigns as director
- Thibaut Santiard, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Thibaut Santiard",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "ADVANZ PHARMA BELGIUM"
}
}06-04-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Advanz Pharma Belgium",
"old": "CORREVIO BELGIUM",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "CORREVIO BELGIUM"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"old": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"changed": false
}
}22-06-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "CORREVIO BELGIUM"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
"changed": false
}
}01-07-2019 SCRL Enst & Young appointed as commissaire
- SCRL Enst & Young, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SCRL Enst \u0026 Young",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "Correvio Belgium"
}
}13-09-2017 1 director appointed, 1 resigning
- Justin Andrew Renz, Gérant
- Jennifer Archibald, Gérant
Technical details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Jennifer Archibald",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Justin Andrew Renz",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "Correvio Belgium"
}
}04-07-2016 Ernst & Young appointed as commissaire
- Ernst & Young, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Ernst \u0026 Young",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "CORREVIO BELGIOM"
}
}18-12-2015 Jürgen Günther resigns as gérant
- Jürgen Günther, Gérant
Technical details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "J\u00FCrgen G\u00FCnther",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "CORREVIO BELGIUM"
}
}31-01-2012 GÜNTHER Jürgen Andreas appointed as manager
- GÜNTHER Jürgen Andreas, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gerant",
"person": {
"rrn": null,
"name": "G\u00DCNTHER J\u00FCrgen Andreas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0833.413.211",
"name_full": "IROKO CARDIO BELGIUM"
}
}| Legal nameFR | Advanz Pharma Belgium |